Patent details

EP3725325 Title: DIABETES THERAPY

Basic Information

Publication number:
EP3725325
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP201738010
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIABETES THERAPY
French Title of Invention:
TRAITEMENT DU DIABÈTE
German Title of Invention:
DIABETESTHERAPIE
SPC Number:

Dates

Filing date:
22/06/2011
Grant date:
31/05/2023
EP Publication Date:
21/10/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/05/2023
EP B1 Publication Date:
31/05/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/06/2023
Expiration date:
22/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/05/2023
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
MARK, Michael
Address:
Germany (DE)

2

Name:
THOMAS, Leo
Address:
Germany (DE)

3

Name:
KLEIN, Thomas
Address:
Germany (DE)

Priority

Priority Number:
10167243
Priority Date:
24/06/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/28; A61K 31/155; A61K 31/522; A61P 1/18; A61P 3/00; A61P 5/50; A61P 9/00; A61P 13/00; A61P 15/08; A61P 17/02; A61P 25/28; A61P 27/12; A61P 29/00; A61P 1/16; A61P 3/04; A61P 3/06; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202322
Publication date:
31/05/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages